Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/16772
Title: Elevated serum interleukin-5 levels in severe chronic obstructive pulmonary disease
Authors: Perret, Jennifer L;McDonald, Christine F;Apostolopoulos, Vasso
Issue Date: 1-Jun-2017
Citation: Acta Biochimica et Biophysica Sinica 2017; 49(1): 560-563
Abstract: Chronic obstructive pulmonary disease (COPD) is a progressive inflammatory lung disorder which is now ranked third as a leading cause of death [1]. Fixed airflow obstruction that is measured by spirometry following inhaled bronchodilator is essential to its diagnosis, and in its advanced stages, systemic manifestations such as inflammation and cachexia are also characteristic. In the lung, pathological features include increased number of airway neutrophils, a cytotoxic (Tc) predominant lymphocytic response associated with lymphoid follicles containing B and T cells, and increased proinflammatory cytokines including interleukin (IL)-6 and IL-8. Lung fibrosis and parenchymal destruction, also known as emphysema, can also be the feature in addition to obstruction of small airways. Some evidence...
URI: http://ahro.austin.org.au/austinjspui/handle/1/16772
DOI: 10.1093/abbs/gmx030
ORCID: 0000-0001-6481-3391
PubMed URL: https://www.ncbi.nlm.nih.gov/pubmed/28398462
Type: Journal Article
Subjects: Cytokine
Chronic obstructive airway disease
Interleukin-5
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.